ACM
ANAB icon

Altium Capital Management’s AnaptysBio ANAB Stock Holding History

Altium Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-206,200
Closed -$2.73M – 27
2024
Q4 		$2.73M Buy
+206,200
New +$4.99M 0.77% 41

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Altium Capital Management's ANAB Position: Q1 2025 in Review

Altium Capital Management sold out of AnaptysBio (ANAB) in Q1 2025, closing a stake of 18,326 shares — an estimated $243K sold.

Altium Capital Management first reported a position in ANAB in Q4 2020 and held it in 2 quarters. The position peaked at $5.62M in Q4 2020. 153 funds tracked by Wall St. Rank hold ANAB as of Q1 2025.

  • Altium Capital Management reported no remaining AnaptysBio position as of Q1 2025 after selling out during the quarter.
  • Altium Capital Management sold 18,326 AnaptysBio shares in Q1 2025, an estimated $243K.
  • Altium Capital Management first reported a position in AnaptysBio in Q4 2020 and held it in 2 quarters.
  • Altium Capital Management's AnaptysBio position peaked at $5.62M in Q4 2020.
  • 153 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2025.

Based on Altium Capital Management's 13F filing for Q1 2025, filed 9 May 2025.